Scientific article

Vaccinologie. Questions autour de la sécurité des vaccins adjuvantes contre la grippe A(H1N1)

Other titleVaccine update 2009: questions around the safety of the influenza A (H1N1) vaccine
Published inRevue médicale suisse, vol. 6, no. 231, p. 67-70
Publication date2010

This manuscript reviews the main vaccine safety concerns that have limited the confidence of the population vis-a-vis influenza A(H1N1) vaccines and disturbed health professionals: A hasty development process? Excessively strong adjuvants? Notoriously toxic substances such as squalene and mercury salts? High risks of Guillain-Barre syndrome or auto-immune diseases? Deaths and other severe problems following immunization? Providing the available information, this manuscript asks whether a high-quality scientific communication would have reassured health professionals, and thus the population. The huge number of questions sent by professionals to InfoVac experts (www.infovac.ch), and the expressed gratitude, allows for some hope.

  • Humans
  • Influenza A Virus, H1N1 Subtype/*immunology
  • Influenza Vaccines/*adverse effects
  • Influenza, Human/*prevention & control
Citation (ISO format)
SIEGRIST, Claire-Anne. Vaccinologie. Questions autour de la sécurité des vaccins adjuvantes contre la grippe A(H1N1). In: Revue médicale suisse, 2010, vol. 6, n° 231, p. 67–70.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation05/22/2012 3:15:42 PM
First validation05/22/2012 3:15:42 PM
Update time03/14/2023 5:30:10 PM
Status update03/14/2023 5:30:10 PM
Last indexation01/15/2024 11:39:17 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack